You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

BETADINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Betadine patents expire, and when can generic versions of Betadine launch?

Betadine is a drug marketed by Alcon Pharms Ltd and is included in one NDA.

The generic ingredient in BETADINE is povidone-iodine. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the povidone-iodine profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BETADINE?
  • What are the global sales for BETADINE?
  • What is Average Wholesale Price for BETADINE?
Summary for BETADINE
Drug patent expirations by year for BETADINE
Drug Prices for BETADINE

See drug prices for BETADINE

Drug Sales Revenue Trends for BETADINE

See drug sales revenues for BETADINE

Recent Clinical Trials for BETADINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The University of The West IndiesEarly Phase 1
Next Science LLCPhase 4
St. Louis UniversityPhase 4

See all BETADINE clinical trials

US Patents and Regulatory Information for BETADINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Pharms Ltd BETADINE povidone-iodine SOLUTION/DROPS;OPHTHALMIC 018634-001 Dec 17, 1986 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

BETADINE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Povidone Iodine (BETADINE)

Introduction to Povidone Iodine (BETADINE)

Povidone iodine, commonly known by the brand name BETADINE, is a chemical complex of iodine that has potent antiseptic properties. It is widely used in various medical and healthcare applications, including wound care, surgical procedures, and as a topical disinfectant.

Global Market Size and Growth

The global povidone iodine market has been experiencing steady growth. As of 2021, the market size was valued at approximately USD 151.5 million to USD 155.5 million[2][3][4].

  • By 2030, the market is projected to reach USD 221.29 million to USD 243.3 million, growing at a Compound Annual Growth Rate (CAGR) of 4.4% to 5.1% during the forecast period[1][3][4].

Regional Insights

  • North America: This region leads the povidone iodine market, with the United States being a significant end-user due to its high rate of hospital-acquired illnesses. Regulatory bodies like the FDA and CDC have implemented strict requirements for surgical antiseptics, further boosting demand[1][4].
  • Asia Pacific: The APAC region is also a major market, driven by the rapidly growing healthcare sectors in countries like China, India, Malaysia, and Thailand. This region is expected to see significant growth, with a CAGR of over 5.5%[1][4].

Market Segmentation

The povidone iodine market is segmented based on formulation type, concentration, and application.

  • Formulation Type: The market includes segments such as scrub, topical solution, and ointments. The scrub segment dominated the market in 2021 with a 42% market share[4].
  • Concentration: The 10% solution segment holds a significant share, accounting for around 58% of the market revenue in 2021. This concentration is widely used as a topical skin cleansing agent and hand scrubbing agent for clinical purposes[2][4].

Growth Drivers

Several factors are driving the growth of the povidone iodine market:

  • Increasing Demand for Antiseptics: The growing need for infection control in healthcare settings and the emphasis on hygiene in various industries are key drivers[3].
  • Advancements in Medical Technology: Continuous advancements in medical technology and the prevalence of chronic wounds are contributing to the market's expansion[3].
  • Regulatory Requirements: Strict regulations by health authorities like the FDA and CDC for surgical antiseptics also drive the demand for povidone iodine[1].

Recent Developments and Market Strategies

Companies in the povidone iodine market are implementing various strategies to enhance their market share:

  • Product Launches: In February 2021, Avrio Health introduced an antiseptic oral rinse product containing povidone-iodine 0.5% under the brand name BETADINE. This product is designed for professional use before dental procedures[2][4].
  • Production Capacity Expansion and Mergers & Acquisitions: Market players are expanding their production capacities and engaging in mergers and acquisitions to tap into growth opportunities and enhance their product portfolios[2].

Challenges and Opportunities

  • Environmental Concerns: The market faces challenges related to environmental concerns and the potential for alternative products. This necessitates the adoption of sustainable practices and innovative product offerings[3].
  • Emerging Markets: There are significant opportunities for expansion into emerging markets, which can provide new revenue streams and diversify the geographical presence of companies[5].

Financial Performance and Competitive Landscape

Companies in the povidone iodine market have demonstrated robust financial performance, characterized by increasing revenue and profitability. This financial stability allows them to invest in innovation, expansion, and strategic initiatives.

  • Strong Brand Reputation: Companies like Avrio Health enjoy a well-established brand reputation, which fosters customer loyalty and attracts new customers[5].
  • Technological Integration: There is an opportunity for companies to enhance operational efficiency and customer experience through technological advancements such as automation and data analytics[5].

Key Takeaways

  • The povidone iodine market is expected to grow significantly, driven by increasing demand for antiseptics and advancements in medical technology.
  • North America and the Asia Pacific are key regions driving the market growth.
  • Companies are focusing on product launches, production capacity expansion, and mergers & acquisitions to stay competitive.
  • Environmental concerns and the need for sustainable practices are critical challenges that need to be addressed.

FAQs

1. What is the projected market size of the povidone iodine market by 2030? The povidone iodine market is expected to reach USD 221.29 million to USD 243.3 million by 2030[1][3][4].

2. Which region leads the povidone iodine market? North America leads the povidone iodine market, with the United States being a significant end-user[1][4].

3. What are the primary applications of povidone iodine? Povidone iodine is extensively used in wound care, surgical procedures, and as a topical disinfectant[3].

4. What are the key growth drivers for the povidone iodine market? The growing demand for infection control, advancements in medical technology, and strict regulatory requirements are key drivers[3].

5. What recent developments have occurred in the povidone iodine market? Recent developments include the launch of new products such as Avrio Health's antiseptic oral rinse containing povidone-iodine 0.5% under the brand name BETADINE[2][4].

Cited Sources:

  1. Maximize Market Research - Povidone Iodine Market: Global Industry Forecast 2030
  2. GMI Insights - Povidone Iodine Market Share Forecasts 2022-2028
  3. SkyQuest Technology - Povidone Iodine Market Report: Size, Share & Forecast | 2031
  4. Spherical Insights - Povidone Iodine Market, Size, Share, Industry, Forecast
  5. Data Bridge Market Research - Global Povidone Iodine Market Top Companies List

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.